Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL SPECIMEN COLLECTION KIT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL SPECIMEN COLLECTION KIT MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL SPECIMEN COLLECTION KIT MARKET : RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EPIDEMIOLOGY
7 INDUSTRY INSIGHTS
8 REGULATORY SCENARIO
9 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY PRODUCT TYPE
9.1 OVERVIEW
9.2 BLOOD COLLECTION KITS
9.2.1 BLOOD COLLECTION TUBES
9.2.1.1. SERUM TUBES
9.2.1.1.1. GLASS
9.2.1.1.1.1 MARKET VALUE (USD MILLION)
9.2.1.1.1.2 MARKET VOLUME(UNITS)
9.2.1.1.1.3 AVEARGE SELLING PRICE(ASP)
9.2.1.1.2. PLASTIC
9.2.1.1.2.1 MARKET VALUE (USD MILLION)
9.2.1.1.2.2 MARKET VOLUME(UNITS)
9.2.1.1.2.3 AVEARGE SELLING PRICE(ASP)
9.2.1.1.3. OTHERS
9.2.1.2. PLASMA/WHOLE BLOOD TUBES
9.2.1.2.1. EDTA TUBES
9.2.1.2.1.1 GLASS
9.2.1.2.1.1.1. MARKET VALUE (USD MILLION)
9.2.1.2.1.1.2. MARKET VOLUME(UNITS)
9.2.1.2.1.1.3. AVEARGE SELLING PRICE(ASP)
9.2.1.2.1.2 PLASTIC
9.2.1.2.1.2.1. MARKET VALUE (USD MILLION)
9.2.1.2.1.2.2. MARKET VOLUME(UNITS)
9.2.1.2.1.2.3. AVEARGE SELLING PRICE(ASP)
9.2.1.2.2. LITHIUM HEPARIN TUBES
9.2.1.2.2.1 GLASS
9.2.1.2.2.1.1. MARKET VALUE (USD MILLION)
9.2.1.2.2.1.2. MARKET VOLUME(UNITS)
9.2.1.2.2.1.3. AVEARGE SELLING PRICE(ASP)
9.2.1.2.2.2 PLASTIC
9.2.1.2.2.2.1. MARKET VALUE (USD MILLION)
9.2.1.2.2.2.2. MARKET VOLUME(UNITS)
9.2.1.2.2.2.3. AVEARGE SELLING PRICE(ASP)
9.2.1.2.3. SODIUM HEPARIN TUBES
9.2.1.2.3.1 GLASS
9.2.1.2.3.1.1. MARKET VALUE (USD MILLION)
9.2.1.2.3.1.2. MARKET VOLUME(UNITS)
9.2.1.2.3.1.3. AVEARGE SELLING PRICE(ASP)
9.2.1.2.3.2 PLASTIC
9.2.1.2.3.2.1. MARKET VALUE (USD MILLION)
9.2.1.2.3.2.2. MARKET VOLUME(UNITS)
9.2.1.2.3.2.3. AVEARGE SELLING PRICE(ASP)
9.2.1.2.4. OTHERS
9.2.1.3. GLUCOSE TUBES
9.2.1.3.1. SODIUM FLUORIDE
9.2.1.3.1.1 PLASTIC
9.2.1.3.1.1.1. MARKET VALUE (USD MILLION)
9.2.1.3.1.1.2. MARKET VOLUME(UNITS)
9.2.1.3.1.1.3. AVEARGE SELLING PRICE(ASP)
9.2.1.3.1.2 GLASS
9.2.1.3.1.2.1. MARKET VALUE (USD MILLION)
9.2.1.3.1.2.2. MARKET VOLUME(UNITS)
9.2.1.3.1.2.3. AVEARGE SELLING PRICE(ASP)
9.2.1.3.2. POTASSIUM FLUORIDE
9.2.1.3.2.1 PLASTIC
9.2.1.3.2.1.1. MARKET VALUE (USD MILLION)
9.2.1.3.2.1.2. MARKET VOLUME(UNITS)
9.2.1.3.2.1.3. AVEARGE SELLING PRICE(ASP)
9.2.1.3.2.2 GLASS
9.2.1.3.2.2.1. MARKET VALUE (USD MILLION)
9.2.1.3.2.2.2. MARKET VOLUME(UNITS)
9.2.1.3.2.2.3. AVEARGE SELLING PRICE(ASP)
9.2.1.3.3. FLUORIDE OXALATE
9.2.1.3.3.1 PLASTIC
9.2.1.3.3.1.1. MARKET VALUE (USD MILLION)
9.2.1.3.3.1.2. MARKET VOLUME(UNITS)
9.2.1.3.3.1.3. AVEARGE SELLING PRICE(ASP)
9.2.1.3.3.2 GLASS
9.2.1.3.3.2.1. MARKET VALUE (USD MILLION)
9.2.1.3.3.2.2. MARKET VOLUME(UNITS)
9.2.1.3.3.2.3. AVEARGE SELLING PRICE(ASP)
9.2.1.3.4. OTHERS
9.2.1.4. ERYTHROCYTE SEDIMENTATION RATE (ESR) TUBES
9.2.1.4.1. PLASTIC
9.2.1.4.1.1 MARKET VALUE (USD MILLION)
9.2.1.4.1.2 MARKET VOLUME(UNITS)
9.2.1.4.1.3 AVEARGE SELLING PRICE(ASP)
9.2.1.4.2. GLASS
9.2.1.4.2.1 MARKET VALUE (USD MILLION)
9.2.1.4.2.2 MARKET VOLUME(UNITS)
9.2.1.4.2.3 AVEARGE SELLING PRICE(ASP)
9.2.1.5. SERUM-SEPARATING TUBES
9.2.1.5.1. GLASS
9.2.1.5.1.1 MARKET VALUE (USD MILLION)
9.2.1.5.1.2 MARKET VOLUME(UNITS)
9.2.1.5.1.3 AVEARGE SELLING PRICE(ASP)
9.2.1.5.2. PLASTIC
9.2.1.5.2.1 MARKET VALUE (USD MILLION)
9.2.1.5.2.2 MARKET VOLUME(UNITS)
9.2.1.5.2.3 AVEARGE SELLING PRICE(ASP)
9.2.1.6. RAPID SERUM TUBES
9.2.1.6.1. MARKET VALUE (USD MILLION)
9.2.1.6.2. MARKET VOLUME(UNITS)
9.2.1.6.3. AVEARGE SELLING PRICE(ASP)
9.2.1.7. EDTA TUBES
9.2.1.7.1. MARKET VALUE (USD MILLION)
9.2.1.7.2. MARKET VOLUME(UNITS)
9.2.1.7.3. AVEARGE SELLING PRICE(ASP)
9.2.1.8. OTHERS
9.2.2 BLOOD BAGS
9.2.2.1. SINGLE BLOOD BAG
9.2.2.1.1. 0 ML – 100 ML
9.2.2.1.1.1 MARKET VALUE (USD MILLION)
9.2.2.1.1.2 MARKET VOLUME(UNITS)
9.2.2.1.1.3 AVEARGE SELLING PRICE(ASP)
9.2.2.1.2. 100 ML – 250 ML
9.2.2.1.2.1 MARKET VALUE (USD MILLION)
9.2.2.1.2.2 MARKET VOLUME(UNITS)
9.2.2.1.2.3 AVEARGE SELLING PRICE(ASP)
9.2.2.1.3. 250 ML -450 ML
9.2.2.1.3.1 MARKET VALUE (USD MILLION)
9.2.2.1.3.2 MARKET VOLUME(UNITS)
9.2.2.1.3.3 AVEARGE SELLING PRICE(ASP)
9.2.2.1.4. 450 ML – 700 ML
9.2.2.1.4.1 MARKET VALUE (USD MILLION)
9.2.2.1.4.2 MARKET VOLUME(UNITS)
9.2.2.1.4.3 AVEARGE SELLING PRICE(ASP)
9.2.2.1.5. 700 ML – 1000 ML
9.2.2.1.5.1 MARKET VALUE (USD MILLION)
9.2.2.1.5.2 MARKET VOLUME(UNITS)
9.2.2.1.5.3 AVEARGE SELLING PRICE(ASP)
9.2.2.1.6. OTHERS
9.2.2.2. DOUBLE BLOOD BAG
9.2.2.2.1. 0 ML – 100 ML
9.2.2.2.1.1 MARKET VALUE (USD MILLION)
9.2.2.2.1.2 MARKET VOLUME(UNITS)
9.2.2.2.1.3 AVEARGE SELLING PRICE(ASP)
9.2.2.2.2. 100 ML – 250 ML
9.2.2.2.2.1 MARKET VALUE (USD MILLION)
9.2.2.2.2.2 MARKET VOLUME(UNITS)
9.2.2.2.2.3 AVEARGE SELLING PRICE(ASP)
9.2.2.2.3. 250 ML -450 ML
9.2.2.2.3.1 MARKET VALUE (USD MILLION)
9.2.2.2.3.2 MARKET VOLUME(UNITS)
9.2.2.2.3.3 AVEARGE SELLING PRICE(ASP)
9.2.2.2.4. 450 ML – 700 ML
9.2.2.2.4.1 MARKET VALUE (USD MILLION)
9.2.2.2.4.2 MARKET VOLUME(UNITS)
9.2.2.2.4.3 AVEARGE SELLING PRICE(ASP)
9.2.2.2.5. 700 ML – 1000 ML
9.2.2.2.5.1 MARKET VALUE (USD MILLION)
9.2.2.2.5.2 MARKET VOLUME(UNITS)
9.2.2.2.5.3 AVEARGE SELLING PRICE(ASP)
9.2.2.2.6. OTHERS
9.2.2.3. TRIPLE BLOOD BAG
9.2.2.3.1. 0 ML – 100 ML
9.2.2.3.1.1 MARKET VALUE (USD MILLION)
9.2.2.3.1.2 MARKET VOLUME(UNITS)
9.2.2.3.1.3 AVEARGE SELLING PRICE(ASP)
9.2.2.3.2. 100 ML – 250 ML
9.2.2.3.2.1 MARKET VALUE (USD MILLION)
9.2.2.3.2.2 MARKET VOLUME(UNITS)
9.2.2.3.2.3 AVEARGE SELLING PRICE(ASP)
9.2.2.3.3. 250 ML -450 ML
9.2.2.3.3.1 MARKET VALUE (USD MILLION)
9.2.2.3.3.2 MARKET VOLUME(UNITS)
9.2.2.3.3.3 AVEARGE SELLING PRICE(ASP)
9.2.2.3.4. 450 ML – 700 ML
9.2.2.3.4.1 MARKET VALUE (USD MILLION)
9.2.2.3.4.2 MARKET VOLUME(UNITS)
9.2.2.3.4.3 AVEARGE SELLING PRICE(ASP)
9.2.2.3.5. 700 ML – 1000 ML
9.2.2.3.5.1 MARKET VALUE (USD MILLION)
9.2.2.3.5.2 MARKET VOLUME(UNITS)
9.2.2.3.5.3 AVEARGE SELLING PRICE(ASP)
9.2.2.4. OTHERS
9.2.3 CAPILLARY
9.2.3.1. REMOTE CAPILLARY BLOOD COLLECTION DEVICE
9.2.3.1.1. COLLECTION KITS
9.2.3.1.1.1 10 µL
9.2.3.1.1.1.1. MARKET VALUE (USD MILLION)
9.2.3.1.1.1.2. MARKET VOLUME(UNITS)
9.2.3.1.1.1.3. AVEARGE SELLING PRICE(ASP)
9.2.3.1.1.2 20 µL
9.2.3.1.1.2.1. MARKET VALUE (USD MILLION)
9.2.3.1.1.2.2. MARKET VOLUME(UNITS)
9.2.3.1.1.2.3. AVEARGE SELLING PRICE(ASP)
9.2.3.1.1.3 30 µL
9.2.3.1.1.3.1. MARKET VALUE (USD MILLION)
9.2.3.1.1.3.2. MARKET VOLUME(UNITS)
9.2.3.1.1.3.3. AVEARGE SELLING PRICE(ASP)
9.2.3.1.2. CARTRIDGE
9.2.3.1.2.1 MARKET VALUE (USD MILLION)
9.2.3.1.2.2 MARKET VOLUME(UNITS)
9.2.3.1.2.3 AVEARGE SELLING PRICE(ASP)
9.2.3.1.3. CLAMSHELL
9.2.3.1.3.1 MARKET VALUE (USD MILLION)
9.2.3.1.3.2 MARKET VOLUME(UNITS)
9.2.3.1.3.3 AVEARGE SELLING PRICE(ASP)
9.2.3.1.4. AUTORACK
9.2.3.1.4.1 MARKET VALUE (USD MILLION)
9.2.3.1.4.2 MARKET VOLUME(UNITS)
9.2.3.1.4.3 AVEARGE SELLING PRICE(ASP)
9.2.3.2. RAPID TEST CASSETTE
9.2.3.2.1. MARKET VALUE (USD MILLION)
9.2.3.2.2. MARKET VOLUME(UNITS)
9.2.3.2.3. AVEARGE SELLING PRICE(ASP)
9.2.3.3. WEARABLE CAPILLARY BLOOD COLLECTION DEVICE
9.2.3.3.1. MARKET VALUE (USD MILLION)
9.2.3.3.2. MARKET VOLUME(UNITS)
9.2.3.3.3. AVEARGE SELLING PRICE(ASP)
9.2.3.4. AUTO-INJECTION BASED DEVICES
9.2.3.4.1. PEDIATRIC
9.2.3.4.1.1 MARKET VALUE (USD MILLION)
9.2.3.4.1.2 MARKET VOLUME(UNITS)
9.2.3.4.1.3 AVEARGE SELLING PRICE(ASP)
9.2.3.4.2. ADULT BASED
9.2.3.4.2.1 MARKET VALUE (USD MILLION)
9.2.3.4.2.2 MARKET VOLUME(UNITS)
9.2.3.4.2.3 AVEARGE SELLING PRICE(ASP)
9.2.3.5. CAPILLARY BLOOD COLLECTION DEVICES
9.2.3.5.1. LANCETS
9.2.3.5.1.1 SAFETY LANCETS
9.2.3.5.1.1.1. MARKET VALUE (USD MILLION)
9.2.3.5.1.1.2. MARKET VOLUME(UNITS)
9.2.3.5.1.1.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.1.2 LASER LANCET
9.2.3.5.1.2.1. MARKET VALUE (USD MILLION)
9.2.3.5.1.2.2. MARKET VOLUME(UNITS)
9.2.3.5.1.2.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.1.3 HEEL PUNCTURE LANCETS
9.2.3.5.1.3.1. MARKET VALUE (USD MILLION)
9.2.3.5.1.3.2. MARKET VOLUME(UNITS)
9.2.3.5.1.3.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.1.4 CONTACT-ACTIVATED LANCET
9.2.3.5.1.4.1. MARKET VALUE (USD MILLION)
9.2.3.5.1.4.2. MARKET VOLUME(UNITS)
9.2.3.5.1.4.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.1.5 HOMECARE LANCETS
9.2.3.5.1.5.1. MARKET VALUE (USD MILLION)
9.2.3.5.1.5.2. MARKET VOLUME(UNITS)
9.2.3.5.1.5.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.1.6 OTHERS
9.2.3.5.2. MICRO-HEMATOCRIT TUBES
9.2.3.5.2.1 HEPARINIZED
9.2.3.5.2.1.1. MARKET VALUE (USD MILLION)
9.2.3.5.2.1.2. MARKET VOLUME(UNITS)
9.2.3.5.2.1.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.2.2 NON- HEPARINIZED
9.2.3.5.2.2.1. MARKET VALUE (USD MILLION)
9.2.3.5.2.2.2. MARKET VOLUME(UNITS)
9.2.3.5.2.2.3. AVEARGE SELLING PRICE(ASP)
9.2.3.5.3. WARMING DEVICES
9.2.3.5.3.1 MARKET VALUE (USD MILLION)
9.2.3.5.3.2 MARKET VOLUME(UNITS)
9.2.3.5.3.3 AVEARGE SELLING PRICE(ASP)
9.2.3.6. OTHERS
9.2.4 BLOOD COLLECTION DEVICES
9.2.4.1. MANUAL BLOOD COLLECTION
9.2.4.2. AUTOMATED BLOOD COLLECTION
9.2.5 VIALS
9.2.5.1. MARKET VALUE (USD MILLION)
9.2.5.2. MARKET VOLUME(UNITS)
9.2.5.3. AVEARGE SELLING PRICE(ASP)
9.3 SWABS COLLECTION KITS
9.3.1 BY TYPES
9.3.1.1. NARES
9.3.1.2. OROPHARYNGEAL
9.3.1.3. NASOPHARYNGEAL
9.3.2 BY CONFIGURATION
9.3.2.1. REGULAR SWAB
9.3.2.2. FLOCKED SWAB
9.3.2.3. OTHERS
9.3.3 BY TIP MATERIALS
9.3.3.1. POLYESTER
9.3.3.2. NYLON
9.3.3.3. CALCIUM ALGINATE
9.3.3.4. COTTON
9.3.3.5. RAYON
9.3.3.6. FOAM
9.3.3.7. OTHERS
9.3.4 BY SHAFT
9.3.4.1. PLASTIC SHAFTS
9.3.4.2. WOODEN SHAFTS
9.3.4.3. RESINS
9.3.4.4. ALUMINUM
9.3.4.5. OTHERS
9.4 URINE COLLECTION KITS
9.4.1 BY PRODUCT
9.4.1.1. URINARY SAMPLE SYSTEM
9.4.1.1.1. CONTAINERS
9.4.1.1.1.1 MARKET VALUE (USD MILLION)
9.4.1.1.1.2 MARKET VOLUME(UNITS)
9.4.1.1.1.3 AVEARGE SELLING PRICE(ASP)
9.4.1.1.2. CUPS
9.4.1.1.2.1 MARKET VALUE (USD MILLION)
9.4.1.1.2.2 MARKET VOLUME(UNITS)
9.4.1.1.2.3 AVEARGE SELLING PRICE(ASP)
9.4.1.1.3. URINALYSIS TUBES
9.4.1.1.3.1 MARKET VALUE (USD MILLION)
9.4.1.1.3.2 MARKET VOLUME(UNITS)
9.4.1.1.3.3 AVEARGE SELLING PRICE(ASP)
9.4.1.2. URINARY CATHETER
9.4.1.2.1. INDWELLING CATHETER
9.4.1.2.1.1 FOLEY CATHETER
9.4.1.2.1.1.1. MARKET VALUE (USD MILLION)
9.4.1.2.1.1.2. MARKET VOLUME(UNITS)
9.4.1.2.1.1.3. AVEARGE SELLING PRICE(ASP)
9.4.1.2.1.2 SUPRAPUBIC CATHETER
9.4.1.2.1.2.1. MARKET VALUE (USD MILLION)
9.4.1.2.1.2.2. MARKET VOLUME(UNITS)
9.4.1.2.1.2.3. AVEARGE SELLING PRICE(ASP)
9.4.1.2.2. INTERMITTENT CATHETER
9.4.1.2.2.1 MARKET VALUE (USD MILLION)
9.4.1.2.2.2 MARKET VOLUME(UNITS)
9.4.1.2.2.3 AVEARGE SELLING PRICE(ASP)
9.4.1.2.3. EXTERNAL CATHETER
9.4.1.2.3.1 MARKET VALUE (USD MILLION)
9.4.1.2.3.2 MARKET VOLUME(UNITS)
9.4.1.2.3.3 AVEARGE SELLING PRICE(ASP)
9.4.1.3. URINE BAGS
9.4.1.3.1. URINARY LEG BAGS
9.4.1.3.1.1 MARKET VALUE (USD MILLION)
9.4.1.3.1.2 MARKET VOLUME(UNITS)
9.4.1.3.1.3 AVEARGE SELLING PRICE(ASP)
9.4.1.3.2. URINARY DRAINAGE BAGS
9.4.1.3.2.1 MARKET VALUE (USD MILLION)
9.4.1.3.2.2 MARKET VOLUME(UNITS)
9.4.1.3.2.3 AVEARGE SELLING PRICE(ASP)
9.4.1.3.3. URINARY BELLY BAGS
9.4.1.3.3.1 MARKET VALUE (USD MILLION)
9.4.1.3.3.2 MARKET VOLUME(UNITS)
9.4.1.3.3.3 AVEARGE SELLING PRICE(ASP)
9.4.1.4. ACCESSORIES
9.4.1.4.1. MARKET VALUE (USD MILLION)
9.4.1.4.2. MARKET VOLUME(UNITS)
9.4.1.4.3. AVEARGE SELLING PRICE(ASP)
9.4.2 BY MATERIAL
9.4.2.1. SILICON
9.4.2.1.1. MARKET VALUE (USD MILLION)
9.4.2.1.2. MARKET VOLUME(UNITS)
9.4.2.1.3. AVEARGE SELLING PRICE(ASP)
9.4.2.2. LATEX
9.4.2.2.1. MARKET VALUE (USD MILLION)
9.4.2.2.2. MARKET VOLUME(UNITS)
9.4.2.2.3. AVEARGE SELLING PRICE(ASP)
9.4.2.3. RUBBER
9.4.2.3.1. MARKET VALUE (USD MILLION)
9.4.2.3.2. MARKET VOLUME(UNITS)
9.4.2.3.3. AVEARGE SELLING PRICE(ASP)
9.4.2.4. OTHERS
9.5 FLUID COLLECTION KITS
9.5.1 CEREBROSPINAL FLUID (CSF) TUBES
9.5.1.1. MARKET VALUE (USD MILLION)
9.5.1.2. MARKET VOLUME(UNITS)
9.5.1.3. AVEARGE SELLING PRICE(ASP)
9.5.2 AMNIOTIC FLUID TUBES
9.5.2.1. MARKET VALUE (USD MILLION)
9.5.2.2. MARKET VOLUME(UNITS)
9.5.2.3. AVEARGE SELLING PRICE(ASP)
9.5.3 OTHERS
9.6 SEMEN COLLECTION KITS
9.6.1 NON-SPERMICIDAL POLYURETHANE CONDOM
9.6.1.1. MARKET VALUE (USD MILLION)
9.6.1.2. MARKET VOLUME(UNITS)
9.6.1.3. AVEARGE SELLING PRICE(ASP)
9.6.2 VIALS
9.6.2.1. MARKET VALUE (USD MILLION)
9.6.2.2. MARKET VOLUME(UNITS)
9.6.2.3. AVEARGE SELLING PRICE(ASP)
9.6.3 OTHERS
9.7 STOOL COLLECTION KITS
9.8 VIRAL TRANSPORT MEDIA
9.9 OTHERS
10 GLOBAL SPECIMEN COLLECTION MARKET, BY MODALITY
10.1 OVERVIEW
10.2 MANUAL
10.3 AUTOMATED
11 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY APPLICATION
11.1 OVERVIEW
11.2 DIAGNOSTICS
11.2.1 INFECTIOUS DISEASES
11.2.2 NON-INFECTIOUS DISEASES
11.2.3 OTHERS
11.3 RESEARCH
11.4 OTHER
12 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY AGE
12.1 OVERVIEW
12.2 PEDIATRIC
12.3 ADULTS
12.4 GERIATRICS
13 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY GENDER
13.1 OVERVIEW
13.2 MALE
13.3 FEMALE
14 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY SITE OF COLLECTION
14.1 OVERVIEW
14.2 HOME BASED COLLECTION
14.3 LABORATORIES BASED COLLECTION
15 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS
15.2.1 GOVERNMENT
15.2.1.1. MILITARY HOSPITAL
15.2.1.2. PUBLIC HOSPITAL
15.2.1.2.1. 100 BED HOSPITAL
15.2.1.2.2. 100-200 BED HOSPITAL
15.2.1.2.3. ABOVE BED HOSPITAL
15.2.2 PRIVATE
15.2.2.1. 100 BED HOSPITAL
15.2.2.2. 100-200 BED HOSPITAL
15.2.2.3. ABOVE BED HOSPITAL
15.3 CLINICS
15.4 DIAGNOSTIC LABORATORIES
15.4.1 PATHOLOGY
15.4.1.1. GOVERNMENT
15.4.1.2. PRIVATE
15.4.2 LAB CHAINS
15.4.2.1. GOVERNMENT
15.4.2.2. PRIVATE
15.4.3 REFERRAL LABS
15.4.3.1. GOVERNMENT
15.4.3.2. PRIVATE
15.4.4 OTHERS
15.5 BLOOD BANKS
15.6 RESEARCH INSTITUTIONS & ACADEMIC
15.7 HOME HEALTHCARE
15.8 OTHERS
16 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 GLOBAL SPECIMEN COLLECTION KIT MARKET , COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.3 COMPANY SHARE ANALYSIS: EUROPE
17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17.5 MERGERS & ACQUISITIONS
17.6 NEW PRODUCT DEVELOPMENT & APPROVALS
17.7 EXPANSIONS
17.8 REGULATORY CHANGES
17.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
18 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY GEOGRAPHY
GLOBAL SPECIMEN COLLECTION KIT MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
18.1 NORTH AMERICA
18.1.1 U.S.
18.1.2 CANADA
18.1.3 MEXICO
18.2 EUROPE
18.2.1 GERMANY
18.2.2 FRANCE
18.2.3 U.K.
18.2.4 HUNGARY
18.2.5 LITHUANIA
18.2.6 AUSTRIA
18.2.7 IRELAND
18.2.8 NORWAY
18.2.9 POLAND
18.2.10 ITALY
18.2.11 SPAIN
18.2.12 RUSSIA
18.2.13 TURKEY
18.2.14 NETHERLANDS
18.2.15 SWITZERLAND
18.2.16 REST OF EUROPE
18.3 ASIA-PACIFIC
18.3.1 JAPAN
18.3.2 CHINA
18.3.3 SOUTH KOREA
18.3.4 INDIA
18.3.5 SINGAPORE
18.3.6 THAILAND
18.3.7 INDONESIA
18.3.8 MALAYSIA
18.3.9 PHILIPPINES
18.3.10 AUSTRALIA
18.3.11 NEW ZEALAND
18.3.12 VIETNAM
18.3.13 TAIWAN
18.3.14 REST OF ASIA-PACIFIC REST OF ASIA-PACIFIC
18.4 SOUTH AMERICA
18.4.1 BRAZIL
18.4.2 ARGENTINA
18.4.3 REST OF SOUTH AMERICA
18.5 MIDDLE EAST AND AFRICA
18.5.1 SOUTH AFRICA
18.5.2 EGYPT
18.5.3 BAHRAIN
18.5.4 UNITED ARAB EMIRATES
18.5.5 KUWAIT
18.5.6 OMAN
18.5.7 QATAR
18.5.8 SAUDI ARABIA
18.5.9 REST OF MIDDLE EAST AND AFRICA
18.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
19 GLOBAL SPECIMEN COLLECTION KIT MARKET , SWOT AND DBMR ANALYSIS
20 GLOBAL SPECIMEN COLLECTION KIT MARKET , COMPANY PROFILE
20.1 ABBOTT
20.1.1 COMPANY OVERVIEW
20.1.2 REVENUE ANALYSIS
20.1.3 GEOGRAPHIC PRESENCE
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 BD
20.2.1 COMPANY OVERVIEW
20.2.2 REVENUE ANALYSIS
20.2.3 GEOGRAPHIC PRESENCE
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 THERMO FISHER SCIENTIFIC INC.
20.3.1 COMPANY OVERVIEW
20.3.2 REVENUE ANALYSIS
20.3.3 GEOGRAPHIC PRESENCE
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENTS
20.4 F. HOFFMANN-LA ROCHE LTD
20.4.1 COMPANY OVERVIEW
20.4.2 REVENUE ANALYSIS
20.4.3 GEOGRAPHIC PRESENCE
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 B. BRAUN SE
20.5.1 COMPANY OVERVIEW
20.5.2 REVENUE ANALYSIS
20.5.3 GEOGRAPHIC PRESENCE
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 QUIDEL CORPORATION
20.6.1 COMPANY OVERVIEW
20.6.2 REVENUE ANALYSIS
20.6.3 GEOGRAPHIC PRESENCE
20.6.4 PRODUCT PORTFOLIO
20.6.5 RECENT DEVELOPMENTS
20.7 SMITHS MEDICAL
20.7.1 COMPANY OVERVIEW
20.7.2 REVENUE ANALYSIS
20.7.3 GEOGRAPHIC PRESENCE
20.7.4 PRODUCT PORTFOLIO
20.7.5 RECENT DEVELOPMENTS
20.8 BIOMÉRIEUX SA
20.8.1 COMPANY OVERVIEW
20.8.2 REVENUE ANALYSIS
20.8.3 GEOGRAPHIC PRESENCE
20.8.4 PRODUCT PORTFOLIO
20.8.5 RECENT DEVELOPMENTS
20.9 CARDINAL HEALTH.
20.9.1 COMPANY OVERVIEW
20.9.2 REVENUE ANALYSIS
20.9.3 GEOGRAPHIC PRESENCE
20.9.4 PRODUCT PORTFOLIO
20.9.5 RECENT DEVELOPMENTS
20.1 BIO-RAD LABORATORIES, INC.
20.10.1 COMPANY OVERVIEW
20.10.2 REVENUE ANALYSIS
20.10.3 GEOGRAPHIC PRESENCE
20.10.4 PRODUCT PORTFOLIO
20.10.5 RECENT DEVELOPMENTS
20.11 TRINITY BIOTECH
20.11.1 COMPANY OVERVIEW
20.11.2 REVENUE ANALYSIS
20.11.3 GEOGRAPHIC PRESENCE
20.11.4 PRODUCT PORTFOLIO
20.11.5 RECENT DEVELOPMENTS
20.12 GERRESHEIMER AG
20.12.1 COMPANY OVERVIEW
20.12.2 REVENUE ANALYSIS
20.12.3 GEOGRAPHIC PRESENCE
20.12.4 PRODUCT PORTFOLIO
20.12.5 RECENT DEVELOPMENTS
20.13 QIAGEN
20.13.1 COMPANY OVERVIEW
20.13.2 REVENUE ANALYSIS
20.13.3 GEOGRAPHIC PRESENCE
20.13.4 PRODUCT PORTFOLIO
20.13.5 RECENT DEVELOPMENTS
20.14 NORGEN BIOTEK CORP.
20.14.1 COMPANY OVERVIEW
20.14.2 REVENUE ANALYSIS
20.14.3 GEOGRAPHIC PRESENCE
20.14.4 PRODUCT PORTFOLIO
20.14.5 RECENT DEVELOPMENTS
20.15 MEDTRONIC
20.15.1 COMPANY OVERVIEW
20.15.2 REVENUE ANALYSIS
20.15.3 GEOGRAPHIC PRESENCE
20.15.4 PRODUCT PORTFOLIO
20.15.5 RECENT DEVELOPMENTS
20.16 GRIFOLS, S.A
20.16.1 COMPANY OVERVIEW
20.16.2 REVENUE ANALYSIS
20.16.3 GEOGRAPHIC PRESENCE
20.16.4 PRODUCT PORTFOLIO
20.16.5 RECENT DEVELOPMENTS
20.17 GOLDWIN MEDICARE
20.17.1 COMPANY OVERVIEW
20.17.2 REVENUE ANALYSIS
20.17.3 GEOGRAPHIC PRESENCE
20.17.4 PRODUCT PORTFOLIO
20.17.5 RECENT DEVELOPMENTS
20.18 EVERLYWELL, INC
20.18.1 COMPANY OVERVIEW
20.18.2 REVENUE ANALYSIS
20.18.3 GEOGRAPHIC PRESENCE
20.18.4 PRODUCT PORTFOLIO
20.18.5 RECENT DEVELOPMENTS
20.19 COPAN DIAGNOSTICS INC
20.19.1 COMPANY OVERVIEW
20.19.2 REVENUE ANALYSIS
20.19.3 GEOGRAPHIC PRESENCE
20.19.4 PRODUCT PORTFOLIO
20.19.5 RECENT DEVELOPMENTS
20.2 QUEST DIAGNOSTICS
20.20.1 COMPANY OVERVIEW
20.20.2 REVENUE ANALYSIS
20.20.3 GEOGRAPHIC PRESENCE
20.20.4 PRODUCT PORTFOLIO
20.20.5 RECENT DEVELOPMENTS
20.21 HOLOGIC, INC.
20.21.1 COMPANY OVERVIEW
20.21.2 REVENUE ANALYSIS
20.21.3 GEOGRAPHIC PRESENCE
20.21.4 PRODUCT PORTFOLIO
20.21.5 RECENT DEVELOPMENTS
20.22 GENEDX, LLC
20.22.1 COMPANY OVERVIEW
20.22.2 REVENUE ANALYSIS
20.22.3 GEOGRAPHIC PRESENCE
20.22.4 PRODUCT PORTFOLIO
20.22.5 RECENT DEVELOPMENTS
20.23 TITAN BIOTECH LIMITED
20.23.1 COMPANY OVERVIEW
20.23.2 REVENUE ANALYSIS
20.23.3 GEOGRAPHIC PRESENCE
20.23.4 PRODUCT PORTFOLIO
20.23.5 RECENT DEVELOPMENTS
20.24 PURITAN MEDICAL PRODUCTS
20.24.1 COMPANY OVERVIEW
20.24.2 REVENUE ANALYSIS
20.24.3 GEOGRAPHIC PRESENCE
20.24.4 PRODUCT PORTFOLIO
20.24.5 RECENT DEVELOPMENTS
20.25 PATH-TEC, LLC
20.25.1 COMPANY OVERVIEW
20.25.2 REVENUE ANALYSIS
20.25.3 GEOGRAPHIC PRESENCE
20.25.4 PRODUCT PORTFOLIO
20.25.5 RECENT DEVELOPMENTS
20.26 LUCENCE HEALTH INC.
20.26.1 COMPANY OVERVIEW
20.26.2 REVENUE ANALYSIS
20.26.3 GEOGRAPHIC PRESENCE
20.26.4 PRODUCT PORTFOLIO
20.26.5 RECENT DEVELOPMENTS
20.27 HARDY DIAGNOSTICS
20.27.1 COMPANY OVERVIEW
20.27.2 REVENUE ANALYSIS
20.27.3 GEOGRAPHIC PRESENCE
20.27.4 PRODUCT PORTFOLIO
20.27.5 RECENT DEVELOPMENTS
20.28 HIMEDIA LABORATORIES
20.28.1 COMPANY OVERVIEW
20.28.2 REVENUE ANALYSIS
20.28.3 GEOGRAPHIC PRESENCE
20.28.4 PRODUCT PORTFOLIO
20.28.5 RECENT DEVELOPMENTS
20.29 MEDLINE INDUSTRIES, LP
20.29.1 COMPANY OVERVIEW
20.29.2 REVENUE ANALYSIS
20.29.3 GEOGRAPHIC PRESENCE
20.29.4 PRODUCT PORTFOLIO
20.29.5 RECENT DEVELOPMENTS
20.3 BTNX INC.
20.30.1 COMPANY OVERVIEW
20.30.2 REVENUE ANALYSIS
20.30.3 GEOGRAPHIC PRESENCE
20.30.4 PRODUCT PORTFOLIO
20.30.5 RECENT DEVELOPMENTS
20.31 DIASORIN MOLECULAR LLC.
20.31.1 COMPANY OVERVIEW
20.31.2 REVENUE ANALYSIS
20.31.3 GEOGRAPHIC PRESENCE
20.31.4 PRODUCT PORTFOLIO
20.31.5 RECENT DEVELOPMENTS
20.32 MEDICAL WIRE & EQUIPMENT
20.32.1 COMPANY OVERVIEW
20.32.2 REVENUE ANALYSIS
20.32.3 GEOGRAPHIC PRESENCE
20.32.4 PRODUCT PORTFOLIO
20.32.5 RECENT DEVELOPMENTS
20.33 MIRACLEAN TECHNOLOGY CO.,LTD.
20.33.1 COMPANY OVERVIEW
20.33.2 REVENUE ANALYSIS
20.33.3 GEOGRAPHIC PRESENCE
20.33.4 PRODUCT PORTFOLIO
20.33.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
21 RELATED REPORTS
22 CONCLUSION
23 QUESTIONNAIRE
24 ABOUT DATA BRIDGE MARKET RESEARCH
